Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P Parks

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|December 28, 1989
Survival in children with perinatally acquired human immunodeficiency virus type 1 infectionG B Scott, C Hutto, R W Makuch, et al.
American Journal of Obstetrics and Gynecology|May 1, 1993
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working GroupM J O'Sullivan, P J Boyer, G B Scott, et al.
The Journal of Pediatrics|March 1, 1991
A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1C Hutto, W P Parks, S H Lai, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trailW P Parks, E S Parks, M A Fischl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1986
Human retroviral env and gag polypeptides: serologic assays to measure infectionS B Kanner, C Cheng-Mayer, R B Geffin, et al.
AIDS (London, England)|January 1, 1990
A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative GroupR B Roberts, F B Hollinger, W P Parks, et al.
Transfusion|October 1, 1989
Epidemiologic background of blood donors with antibody to human T-cell lymphotropic virus. Transfusion Safety Study GroupE A Operskalski, E R Schiff, S H Kleinman, et al.
Science (New York, N.Y.)|February 28, 1992
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infantsS M Wolinsky, C M Wike, B T Korber, et al.
Journal of the National Cancer Institute|June 1, 1978
Leukocyte migration inhibition and lymphocyte blastogenesis responses in breast carcinoma patients to mouse mammary tumor virus and to virion gp52 antigen and Rauscher murine leukemia virus-Kirsten sarcoma virus gp69/71 antigenJ L McCoy, J H Dean, G B Cannon, et al.
The Journal of Pediatrics|April 1, 1990
Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study GroupR E McKinney, P A Pizzo, G B Scott, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|December 28, 1989
Survival in children with perinatally acquired human immunodeficiency virus type 1 infectionG B Scott, C Hutto, R W Makuch, et al.
American Journal of Obstetrics and Gynecology|May 1, 1993
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working GroupM J O'Sullivan, P J Boyer, G B Scott, et al.
The Journal of Pediatrics|March 1, 1991
A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1C Hutto, W P Parks, S H Lai, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trailW P Parks, E S Parks, M A Fischl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1986
Human retroviral env and gag polypeptides: serologic assays to measure infectionS B Kanner, C Cheng-Mayer, R B Geffin, et al.
AIDS (London, England)|January 1, 1990
A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative GroupR B Roberts, F B Hollinger, W P Parks, et al.
Transfusion|October 1, 1989
Epidemiologic background of blood donors with antibody to human T-cell lymphotropic virus. Transfusion Safety Study GroupE A Operskalski, E R Schiff, S H Kleinman, et al.
Science (New York, N.Y.)|February 28, 1992
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infantsS M Wolinsky, C M Wike, B T Korber, et al.
Journal of the National Cancer Institute|June 1, 1978
Leukocyte migration inhibition and lymphocyte blastogenesis responses in breast carcinoma patients to mouse mammary tumor virus and to virion gp52 antigen and Rauscher murine leukemia virus-Kirsten sarcoma virus gp69/71 antigenJ L McCoy, J H Dean, G B Cannon, et al.
The Journal of Pediatrics|April 1, 1990
Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study GroupR E McKinney, P A Pizzo, G B Scott, et al.
Pageof 11